Mymediset Launches Agentic AI Solution for Enhanced Medical Supply Chains
In a notable announcement at LogiMed 2026, mymediset has introduced an advanced AI capability named mymediAI, designed to transform the medical supply chain landscape. This innovative solution aims to optimize execution within medical workflows, providing MedTech organizations the means to transition from traditional reactive approaches to autonomous operations.
Operating within the core SAP® environment, mymediAI serves as an orchestration layer, efficiently connecting data, workflows, and decision-making procedures in real-time. This integration addresses longstanding issues in many MedTech sectors where essential tasks, including case reservation, inventory management, and revenue capture, still necessitate extensive manual coordination between disparate systems. This dependency has often resulted in unnecessary administrative burdens, surplus inventories, and delays in recognizing revenue.
MymediAI responds to these challenges directly by embedding intelligent capabilities into the everyday operational workflows. One of its primary features is real-time inventory validation, which supports precise case preparations prior to procedures. For field sales teams, this transformation is particularly significant; mymediAI automates routine tasks like case creation and captures surgeons' preferences instantly. Users benefit from a comprehensive dashboard that presents an up-to-date overview of upcoming activities, ongoing cases, and sales performance—all accessible through a single interface.
Tony Martinez, Managing Director at mymediset North America, emphasized, "Field sales professionals shouldn't be overwhelmed by administrative tasks. MymediAI provides them with the clarity and control necessary to effectively manage each case, allowing them to focus on their essential interaction with customers."
Preliminary results from early adopters of mymediAI have demonstrated impressive operational enhancements. These outcomes include reductions of administrative effort by as much as 90%, cuts in inventory levels by 30%, and tripled speed in revenue recognition. Silke Zschweigert, the CEO of mymediset, commented on these developments, stating, "The landscape of AI application in MedTech is evolving. Companies are now prioritizing execution, ensuring that data translates into actionable outcomes within their operational frameworks. This is the direction toward truly autonomous supply chains."
MymediAI stands apart from various standalone AI instruments and external integrations. Its functionality as an integrated solution within the SAP® system means that core supply chain and financial processes can run seamlessly without necessitating extra middleware or complex system synchronization. By harnessing real-time data coupled with workflow integration, mymediAI empowers systems to anticipate necessary actions and execute them reliably within existing processes.
Ashwin Bhaskar, Chief Technology Officer at mymediset, highlighted the game-changing potential of this agentic AI, asserting, "This technology introduces a transformative capacity in operations. By synthesizing real-time insights with procedural integration, we can ensure that systems not only recognize requirements but also initiate necessary actions effectively within normal workflows. This is merely the beginning; as agentic AI is increasingly woven into everyday operations, we approach the goal of a supply chain that proactively supports care delivery instead of merely responding to it."
The launch of mymediAI indicates a clear move towards the development of more autonomous supply chain models within the MedTech sector. These advancements will bolster end-to-end execution across planning, logistics, and financial facets of supply chains. Integrally linked to the broader mymediset platform—developed on SAP®—mymediAI is poised to enhance the management of field inventory, consignment, and loan set processes, all streamlined from point of production to the patient.
As mymediset continues to push the boundaries of what's achievable within the medical supply chain, it remains committed to ensuring that vital products are available precisely when and where they are needed, enabling healthcare professionals to deliver the best possible patient outcome.